Arizona Dispensary Acquisition: Due Diligence Uncovering Latent License Risk in $18M Deal

Matter Overview

A cannabis investment group under a signed letter of intent to acquire an Arizona dispensary for $18 million engaged Hoban Law Group to conduct regulatory due diligence as part of the pre-closing process. The seller represented the license as "clean" and the operation as in full compliance with the Arizona Department of Health Services (ADHS) Medical Marijuana Program requirements. Standard financial and legal due diligence had been completed by other counsel. Hoban was engaged specifically for the regulatory layer.

Work Performed

Hoban's due diligence team obtained and reviewed three years of ADHS inspection reports, laboratory testing records, and corrective action plans through a combination of public records requests and direct seller disclosure demands. The team also reviewed the dispensary's wholesale purchase records, cultivation site inspection history, and laboratory transfer documentation.

The review surfaced a material finding: the dispensary had self-reported a product testing exceedance to ADHS in 2023 but had failed to complete the mandatory quarantine and destruction protocol. ADHS had issued a notice of non-compliance that the seller had not disclosed in its representations — the document was buried in a file of routine correspondence the seller characterized as "resolved." Additionally, the corrective action plan submitted by the dispensary had been approved by ADHS contingent on a follow-up inspection that had not yet occurred. The license was technically in a conditional compliance status.

Hoban prepared a regulatory risk memorandum quantifying the exposure: in the worst case, the conditional compliance status could result in a license suspension triggering the Material Adverse Change clause in the purchase agreement. In the most likely case, the follow-up inspection would be completed within 60 days post-close — but the buyer would bear that risk without indemnification under the current deal terms.

Outcome

The client used the regulatory risk memorandum to renegotiate the purchase price down by $1.2 million and obtain a specific indemnification escrow of $500,000 held for 18 months against any ADHS enforcement action arising from the pre-close conditional compliance status. The deal closed on revised terms.

Lessons Learned

Seller representations in cannabis M&A are only as reliable as the underlying regulatory record. ADHS non-compliance notices are not automatically discoverable from public records — they require specific direct requests with precise citation to the relevant statutory provision. Regulatory due diligence should be parallel to, not sequential to, financial due diligence; in this matter, the regulatory finding surfaced late because it was scoped as Phase 2.

Engage Hoban Law Group

Hoban Law Group provides regulatory due diligence for cannabis acquisitions across all major licensing states. We identify what other counsel misses. [Schedule a consultation](/consultation?source=matter&matter_slug=dispensary-acquisition-due-diligence-arizona-2025&matter_type=cannabis-mergers-acquisitions).